Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej ( Site 2113)

Gdynia, Pomeranian Voivodeship 81-519

1 studies enrolling now · 1 studies all time

What they study most

Triple-Negative Breast Cancer

Studies at this site

• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) — Recruiting now